Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses
The aim of the present study was to investigate the genetic variability of VKORC1, CYP2C9 and CYP4F2 genes in patients who required a very low and high warfarin dose, in order to identify novel variants that could help to explain the particular extreme dose requirements.
Gespeichert in:
| Autor*in: |
Di Fusco, Davide [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2013 |
|---|
| Umfang: |
4 |
|---|
| Übergeordnetes Werk: |
Enthalten in: DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer - 2012, vascular obstruction, hemorrhage and hemostasis, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:132 ; year:2013 ; number:1 ; pages:123-126 ; extent:4 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.thromres.2013.05.002 |
|---|
| Katalog-ID: |
ELV027716015 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV027716015 | ||
| 003 | DE-627 | ||
| 005 | 20230623191126.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.thromres.2013.05.002 |2 doi | |
| 028 | 5 | 2 | |a GBVA2013023000005.pica |
| 035 | |a (DE-627)ELV027716015 | ||
| 035 | |a (ELSEVIER)S0049-3848(13)00194-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Di Fusco, Davide |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses |
| 264 | 1 | |c 2013 | |
| 300 | |a 4 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a The aim of the present study was to investigate the genetic variability of VKORC1, CYP2C9 and CYP4F2 genes in patients who required a very low and high warfarin dose, in order to identify novel variants that could help to explain the particular extreme dose requirements. | ||
| 700 | 1 | |a Ciccacci, Cinzia |4 oth | |
| 700 | 1 | |a Rufini, Sara |4 oth | |
| 700 | 1 | |a Forte, Vittorio |4 oth | |
| 700 | 1 | |a Novelli, Giuseppe |4 oth | |
| 700 | 1 | |a Borgiani, Paola |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |t DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |d 2012 |d vascular obstruction, hemorrhage and hemostasis |g Amsterdam [u.a.] |w (DE-627)ELV011105356 |
| 773 | 1 | 8 | |g volume:132 |g year:2013 |g number:1 |g pages:123-126 |g extent:4 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.thromres.2013.05.002 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_24 | ||
| 912 | |a GBV_ILN_40 | ||
| 936 | b | k | |a 44.40 |j Pharmazie |j Pharmazeutika |q VZ |
| 951 | |a AR | ||
| 952 | |d 132 |j 2013 |e 1 |h 123-126 |g 4 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
f d d fd fdd |
|---|---|
| matchkey_str |
difuscodavideciccaccicinziarufinisarafor:2013----:eeunigfkr1y29ncpfgnsntlaptetrqiigxrm |
| hierarchy_sort_str |
2013 |
| bklnumber |
44.40 |
| publishDate |
2013 |
| allfields |
10.1016/j.thromres.2013.05.002 doi GBVA2013023000005.pica (DE-627)ELV027716015 (ELSEVIER)S0049-3848(13)00194-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.40 bkl Di Fusco, Davide verfasserin aut Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses 2013 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The aim of the present study was to investigate the genetic variability of VKORC1, CYP2C9 and CYP4F2 genes in patients who required a very low and high warfarin dose, in order to identify novel variants that could help to explain the particular extreme dose requirements. Ciccacci, Cinzia oth Rufini, Sara oth Forte, Vittorio oth Novelli, Giuseppe oth Borgiani, Paola oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:132 year:2013 number:1 pages:123-126 extent:4 https://doi.org/10.1016/j.thromres.2013.05.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 132 2013 1 123-126 4 045F 610 |
| spelling |
10.1016/j.thromres.2013.05.002 doi GBVA2013023000005.pica (DE-627)ELV027716015 (ELSEVIER)S0049-3848(13)00194-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.40 bkl Di Fusco, Davide verfasserin aut Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses 2013 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The aim of the present study was to investigate the genetic variability of VKORC1, CYP2C9 and CYP4F2 genes in patients who required a very low and high warfarin dose, in order to identify novel variants that could help to explain the particular extreme dose requirements. Ciccacci, Cinzia oth Rufini, Sara oth Forte, Vittorio oth Novelli, Giuseppe oth Borgiani, Paola oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:132 year:2013 number:1 pages:123-126 extent:4 https://doi.org/10.1016/j.thromres.2013.05.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 132 2013 1 123-126 4 045F 610 |
| allfields_unstemmed |
10.1016/j.thromres.2013.05.002 doi GBVA2013023000005.pica (DE-627)ELV027716015 (ELSEVIER)S0049-3848(13)00194-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.40 bkl Di Fusco, Davide verfasserin aut Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses 2013 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The aim of the present study was to investigate the genetic variability of VKORC1, CYP2C9 and CYP4F2 genes in patients who required a very low and high warfarin dose, in order to identify novel variants that could help to explain the particular extreme dose requirements. Ciccacci, Cinzia oth Rufini, Sara oth Forte, Vittorio oth Novelli, Giuseppe oth Borgiani, Paola oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:132 year:2013 number:1 pages:123-126 extent:4 https://doi.org/10.1016/j.thromres.2013.05.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 132 2013 1 123-126 4 045F 610 |
| allfieldsGer |
10.1016/j.thromres.2013.05.002 doi GBVA2013023000005.pica (DE-627)ELV027716015 (ELSEVIER)S0049-3848(13)00194-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.40 bkl Di Fusco, Davide verfasserin aut Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses 2013 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The aim of the present study was to investigate the genetic variability of VKORC1, CYP2C9 and CYP4F2 genes in patients who required a very low and high warfarin dose, in order to identify novel variants that could help to explain the particular extreme dose requirements. Ciccacci, Cinzia oth Rufini, Sara oth Forte, Vittorio oth Novelli, Giuseppe oth Borgiani, Paola oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:132 year:2013 number:1 pages:123-126 extent:4 https://doi.org/10.1016/j.thromres.2013.05.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 132 2013 1 123-126 4 045F 610 |
| allfieldsSound |
10.1016/j.thromres.2013.05.002 doi GBVA2013023000005.pica (DE-627)ELV027716015 (ELSEVIER)S0049-3848(13)00194-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.40 bkl Di Fusco, Davide verfasserin aut Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses 2013 4 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The aim of the present study was to investigate the genetic variability of VKORC1, CYP2C9 and CYP4F2 genes in patients who required a very low and high warfarin dose, in order to identify novel variants that could help to explain the particular extreme dose requirements. Ciccacci, Cinzia oth Rufini, Sara oth Forte, Vittorio oth Novelli, Giuseppe oth Borgiani, Paola oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:132 year:2013 number:1 pages:123-126 extent:4 https://doi.org/10.1016/j.thromres.2013.05.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 132 2013 1 123-126 4 045F 610 |
| language |
English |
| source |
Enthalten in DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer Amsterdam [u.a.] volume:132 year:2013 number:1 pages:123-126 extent:4 |
| sourceStr |
Enthalten in DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer Amsterdam [u.a.] volume:132 year:2013 number:1 pages:123-126 extent:4 |
| format_phy_str_mv |
Article |
| bklname |
Pharmazie Pharmazeutika |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
| authorswithroles_txt_mv |
Di Fusco, Davide @@aut@@ Ciccacci, Cinzia @@oth@@ Rufini, Sara @@oth@@ Forte, Vittorio @@oth@@ Novelli, Giuseppe @@oth@@ Borgiani, Paola @@oth@@ |
| publishDateDaySort_date |
2013-01-01T00:00:00Z |
| hierarchy_top_id |
ELV011105356 |
| dewey-sort |
3610 |
| id |
ELV027716015 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV027716015</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623191126.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.thromres.2013.05.002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013023000005.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV027716015</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0049-3848(13)00194-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Di Fusco, Davide</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">4</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The aim of the present study was to investigate the genetic variability of VKORC1, CYP2C9 and CYP4F2 genes in patients who required a very low and high warfarin dose, in order to identify novel variants that could help to explain the particular extreme dose requirements.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ciccacci, Cinzia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rufini, Sara</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Forte, Vittorio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Novelli, Giuseppe</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Borgiani, Paola</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer</subfield><subfield code="d">2012</subfield><subfield code="d">vascular obstruction, hemorrhage and hemostasis</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011105356</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:132</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:123-126</subfield><subfield code="g">extent:4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.thromres.2013.05.002</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="j">Pharmazie</subfield><subfield code="j">Pharmazeutika</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">132</subfield><subfield code="j">2013</subfield><subfield code="e">1</subfield><subfield code="h">123-126</subfield><subfield code="g">4</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Di Fusco, Davide |
| spellingShingle |
Di Fusco, Davide ddc 610 bkl 44.40 Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses |
| authorStr |
Di Fusco, Davide |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV011105356 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ 44.40 bkl Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses |
| topic |
ddc 610 bkl 44.40 |
| topic_unstemmed |
ddc 610 bkl 44.40 |
| topic_browse |
ddc 610 bkl 44.40 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
c c cc s r sr v f vf g n gn p b pb |
| hierarchy_parent_title |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
| hierarchy_parent_id |
ELV011105356 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV011105356 |
| title |
Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses |
| ctrlnum |
(DE-627)ELV027716015 (ELSEVIER)S0049-3848(13)00194-1 |
| title_full |
Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses |
| author_sort |
Di Fusco, Davide |
| journal |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
| journalStr |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2013 |
| contenttype_str_mv |
zzz |
| container_start_page |
123 |
| author_browse |
Di Fusco, Davide |
| container_volume |
132 |
| physical |
4 |
| class |
610 610 DE-600 610 VZ 44.40 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Di Fusco, Davide |
| doi_str_mv |
10.1016/j.thromres.2013.05.002 |
| dewey-full |
610 |
| title_sort |
resequencing of vkorc1, cyp2c9 and cyp4f2 genes in italian patients requiring extreme low and high warfarin doses |
| title_auth |
Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses |
| abstract |
The aim of the present study was to investigate the genetic variability of VKORC1, CYP2C9 and CYP4F2 genes in patients who required a very low and high warfarin dose, in order to identify novel variants that could help to explain the particular extreme dose requirements. |
| abstractGer |
The aim of the present study was to investigate the genetic variability of VKORC1, CYP2C9 and CYP4F2 genes in patients who required a very low and high warfarin dose, in order to identify novel variants that could help to explain the particular extreme dose requirements. |
| abstract_unstemmed |
The aim of the present study was to investigate the genetic variability of VKORC1, CYP2C9 and CYP4F2 genes in patients who required a very low and high warfarin dose, in order to identify novel variants that could help to explain the particular extreme dose requirements. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 |
| container_issue |
1 |
| title_short |
Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses |
| url |
https://doi.org/10.1016/j.thromres.2013.05.002 |
| remote_bool |
true |
| author2 |
Ciccacci, Cinzia Rufini, Sara Forte, Vittorio Novelli, Giuseppe Borgiani, Paola |
| author2Str |
Ciccacci, Cinzia Rufini, Sara Forte, Vittorio Novelli, Giuseppe Borgiani, Paola |
| ppnlink |
ELV011105356 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth |
| doi_str |
10.1016/j.thromres.2013.05.002 |
| up_date |
2024-07-06T16:57:19.715Z |
| _version_ |
1803849605807341568 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV027716015</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623191126.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.thromres.2013.05.002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013023000005.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV027716015</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0049-3848(13)00194-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Di Fusco, Davide</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">4</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The aim of the present study was to investigate the genetic variability of VKORC1, CYP2C9 and CYP4F2 genes in patients who required a very low and high warfarin dose, in order to identify novel variants that could help to explain the particular extreme dose requirements.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ciccacci, Cinzia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rufini, Sara</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Forte, Vittorio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Novelli, Giuseppe</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Borgiani, Paola</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer</subfield><subfield code="d">2012</subfield><subfield code="d">vascular obstruction, hemorrhage and hemostasis</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011105356</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:132</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:123-126</subfield><subfield code="g">extent:4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.thromres.2013.05.002</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="j">Pharmazie</subfield><subfield code="j">Pharmazeutika</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">132</subfield><subfield code="j">2013</subfield><subfield code="e">1</subfield><subfield code="h">123-126</subfield><subfield code="g">4</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.4015245 |